Clinical Trial Update: Treatment With Leflunomide in Patients With Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating leflunomide for polymyalgia rheumatica is in an update, status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Elisabeth Brouwer | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: UNKNOWN